Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Lenvatinib Impurity 22 REF: 4Z-L-124027	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 65 REF: 4Z-C-121068CAS: 2177287-70-4	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 48 REF: 4Z-N-066066CAS: 14719-83-6	- - -	To inquire	Tue 10 Dec 24
Goserelin Impurity 1 (4-(Acetyl-D-Serine)-Goserelin) REF: 4Z-PG-1516	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 59 REF: 4Z-C-121062	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 42 REF: 4Z-P-196049CAS: 1016636-76-2	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 65 REF: 4Z-N-066083CAS: 3395-81-1	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 3 HCl REF: 4Z-B-119006CAS: 129593-20-0 62023-62-5	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 44 REF: 4Z-C-121047	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 22 REF: 4Z-G-047027CAS: 1075-59-8	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 7 REF: 4Z-F-3129CAS: 1673530-91-0	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Related Impurity ((S)-2-amino-4-oxo-4-phenylbutanoic acid hydrochloride) REF: 4Z-C-121003CAS: 168154-76-5	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 92 REF: 4Z-N-066105	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 15 REF: 4Z-P-196019CAS: 51534-82-8	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 14 HCl REF: 4Z-B-119017	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 21 REF: 4Z-F-3136CAS: 757-06-2	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 27 REF: 4Z-E-068040CAS: 403-24-7	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 5 REF: 4Z-F-3119	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 84 REF: 4Z-N-066097	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 49 REF: 4Z-L-124055	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Lenvatinib Impurity 22

Ref: 4Z-L-124027

Carfilzomib Impurity 65

Ref: 4Z-C-121068

Nintedanib Impurity 48

Ref: 4Z-N-066066

Goserelin Impurity 1 (4-(Acetyl-D-Serine)-Goserelin)

Ref: 4Z-PG-1516

Carfilzomib Impurity 59

Ref: 4Z-C-121062

Palbociclib Impurity 42

Ref: 4Z-P-196049

Nintedanib Impurity 65

Ref: 4Z-N-066083

Bestatin Impurity 3 HCl

Ref: 4Z-B-119006

Carfilzomib Impurity 44

Ref: 4Z-C-121047

Gimeracil Impurity 22

Ref: 4Z-G-047027

Fulvestrant Impurity 7

Ref: 4Z-F-3129

Carfilzomib Related Impurity ((S)-2-amino-4-oxo-4-phenylbutanoic acid hydrochloride)

Ref: 4Z-C-121003

Nintedanib Impurity 92

Ref: 4Z-N-066105

Palbociclib Impurity 15

Ref: 4Z-P-196019

Bestatin Impurity 14 HCl

Ref: 4Z-B-119017

Fulvestrant Impurity 21

Ref: 4Z-F-3136

Enzalutamide Impurity 27

Ref: 4Z-E-068040

Fulvestrant Impurity 5

Ref: 4Z-F-3119

Nintedanib Impurity 84

Ref: 4Z-N-066097

Lenvatinib Impurity 49

Ref: 4Z-L-124055